Difference between revisions of "Template:Antiemetics"
Jump to navigation
Jump to search
blackwiki>Götz m (make group column width narrower) |
blackwiki>00AgentBond93 |
||
| Line 7: | Line 7: | ||
| groupstyle = background:#fd6; | | groupstyle = background:#fd6; | ||
| − | | group1 = [[5-HT3 antagonist|5- | + | | group1 = [[5-HT3 antagonist|5-HT3 Serotonin ion channel antagonist]]s |
| list1 = | | list1 = | ||
* [[Alosetron]] | * [[Alosetron]] | ||
| Line 24: | Line 24: | ||
* [[Ondansetron]] | * [[Ondansetron]] | ||
* [[Palonosetron]] | * [[Palonosetron]] | ||
| + | * [[Quetiapine]] | ||
* [[Ramosetron]] | * [[Ramosetron]] | ||
* [[Ricasetron]] | * [[Ricasetron]] | ||
| Line 29: | Line 30: | ||
* [[Zatosetron]] | * [[Zatosetron]] | ||
| − | | group2 = [[CB1 receptor|CB<sub>1</sub>]] [[Agonist]]s<br/> ([[Cannabinoid]]s) | + | | group2 = [[Serotonin antagonist|5-HT Serotonin G-protien receptor antagonist]]s |
| − | | | + | | list2 = |
| + | * [[Clozapine]] | ||
| + | * [[Cyproheptadine]] | ||
| + | * [[Hydroxyzine]] | ||
| + | * [[Olanzepine]] | ||
| + | * [[Risperidone]] | ||
| + | * [[Ziprasidone]] | ||
| + | |||
| + | | group3 = [[CB1 receptor|CB<sub>1</sub>]] [[Agonist]]s<br/> ([[Cannabinoid]]s) | ||
| + | | list3 = | ||
* [[Dronabinol]] | * [[Dronabinol]] | ||
* [[Nabilone]] | * [[Nabilone]] | ||
| Line 36: | Line 46: | ||
* [[Tetrahydrocannabinol]] | * [[Tetrahydrocannabinol]] | ||
| − | | | + | | group4 = [[Dopamine antagonist|D<sub>2</sub>/D<sub>3</sub> Antagonist]]s |
| − | | | + | | list4 = |
* [[Alizapride]] | * [[Alizapride]] | ||
* [[Bromopride]] | * [[Bromopride]] | ||
| Line 44: | Line 54: | ||
* [[Domperidone]] | * [[Domperidone]] | ||
* [[Haloperidol]] | * [[Haloperidol]] | ||
| + | * [[Hydroxyzine]] | ||
* [[Itopride]] | * [[Itopride]] | ||
* [[Metoclopramide]] | * [[Metoclopramide]] | ||
| Line 50: | Line 61: | ||
* [[Thiethylperazine]] | * [[Thiethylperazine]] | ||
| − | | | + | | group5 = [[H1 antagonist|H<sub>1</sub> antagonists]] <br/>([[Histamine antagonist|Antihistamines]]) |
| − | | | + | | list5 = |
* [[Cyclizine]] | * [[Cyclizine]] | ||
* [[Dimenhydrinate]] | * [[Dimenhydrinate]] | ||
* [[Diphenhydramine]] | * [[Diphenhydramine]] | ||
| + | * [[Hydroxyzine]] | ||
* [[Meclozine]] | * [[Meclozine]] | ||
* [[Promethazine]] | * [[Promethazine]] | ||
| − | | | + | | group6 = [[Muscarinic acetylcholine receptor|mACh]] [[Receptor_Antagonist|antagonists]]<br/> ([[Anticholinergic]]s) |
| − | | | + | | list6 = |
* [[Atropine]] | * [[Atropine]] | ||
| + | * [[Diphenhydramine]] | ||
| + | * [[Hydroxyzine]] (very mild) | ||
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
* [[Scopolamine]] | * [[Scopolamine]] | ||
| − | | | + | | group7 = [[NK1 receptor antagonist|NK<sub>1</sub> Antagonists]] |
| − | | | + | | list7 = |
* [[Aprepitant]] | * [[Aprepitant]] | ||
* [[Casopitant]] | * [[Casopitant]] | ||
| Line 73: | Line 87: | ||
* [[Vestipitant]] | * [[Vestipitant]] | ||
| − | | | + | | group8 = Others |
| − | | | + | | list8 = |
* [[Cerium oxalate]] | * [[Cerium oxalate]] | ||
* [[Dexamethasone]] | * [[Dexamethasone]] | ||
Revision as of 16:11, 6 July 2013
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antiemetics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antiemetics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antiemetics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.